A new study published in the journal PLoS One as well as the National Institute of Health has found that cannabis may serve as a treatment for Hodgkin lymphoma, which is a cancer of lymph tissue (found in the spleen, liver, bone marrow and other areas).
For the study, researchers at Goethe-University, Leipzig University and Martin-Luther-University Halle-Wittenberg “examined the distribution of CB1 [cannabinoid receptor 1] protein in primary cases of HL (Hodgkin lymphoma). Using lymphoma derived cell lines, the role of CB1 signaling on cell survival was investigated.”
After conducting the study, researchers concluded that; “The present study identifies CB1 as a feature of HL, which might serve as a potential selective target in the treatment of Hodgkin lymphoma.”
Given that cannabis serves as a direct and natural agonist to our body’s cannabinoid receptors, cannabis may provide an ideal treatment for the cancer, which is responsible for hundreds of deaths each year according to the American Cancer Society.
The study can be found by clicking here.